The therapeutic effects of new type phosphate binder, vitamin D analogue and calcimimetic compound have been evidenced already.
新型磷结合剂、维生素D类似物及钙敏感受体激活剂等现已陆续进入临床,并取得良好疗效。
The core materials consist of soluble phosphate binder, magnesium oxide hardener and high-purity silicon oxide as refractory aggregate materials.
这种芯料采用水溶性磷酸盐为粘结剂、氧化镁为固化剂、高纯二氧化硅为耐火骨料。
Objective: to evaluate the effect of low-calcium peritoneal dialysate and phosphate binder on calcium and phosphate abnormality and coronary artery calcification of end-stage renal disease patients.
目的:评价低钙透析液和含钙的磷结合剂治疗对终末期肾病腹膜透析患者钙磷代谢紊乱和冠状动脉钙化进展的影响。
Objective: to evaluate the effect of low-calcium peritoneal dialysate and phosphate binder on calcium and phosphate abnormality and coronary artery calcification of end-stage renal disease patients.
目的:评价低钙透析液和含钙的磷结合剂治疗对终末期肾病腹膜透析患者钙磷代谢紊乱和冠状动脉钙化进展的影响。
应用推荐